Report cover image

Global Latisse (Bimatoprost) (CAS 155206-00-1) Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Aug 03, 2025
Length 132 Pages
SKU # BOSS20299103

Description

Report Overview

Latisse (Bimatoprost) is a prostaglandin analog primarily used to treat hypotrichosis (inadequate eyelash growth) by promoting longer, thicker, and darker lashes. Originally developed as a glaucoma treatment under the name Lumigan, its secondary cosmetic effect on eyelash growth led to its FDA approval for aesthetic use. The active ingredient, Bimatoprost (CAS 155206-00-1), works by extending the anagen (growth) phase of the eyelash hair cycle and increasing melanin production. Marketed as a prescription-only topical solution, Latisse has gained popularity in the medical aesthetics industry, positioning itself as a leading product in the eyelash enhancement segment. The market for Latisse is driven by increasing consumer demand for non-invasive cosmetic treatments, rising disposable incomes, and growing awareness of FDA-approved aesthetic solutions. However, competition from generic alternatives and over-the-counter serums, along with potential side effects like iris darkening and periorbital fat loss, presents challenges. The product’s growth is further influenced by trends in beauty and wellness, pharmaceutical innovation, and the expansion of dermatology and ophthalmology clinics offering cosmetic procedures.

The global Latisse (Bimatoprost) (CAS 155206-00-1) market size was estimated at USD 7.61 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.28% during the forecast period.

This report provides a deep insight into the global Latisse (Bimatoprost) (CAS 155206-00-1) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Latisse (Bimatoprost) (CAS 155206-00-1) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Latisse (Bimatoprost) (CAS 155206-00-1) market in any manner.

Global Latisse (Bimatoprost) (CAS 155206-00-1) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Allergan plc (AbbVie Inc.)

Sandoz(Novartis)

Hi-Tech Pharmacal

Apotex Inc.

Market Segmentation (by Type)

Medicine Grade

Cosmetic Grade

Market Segmentation (by Application)

Medicine

Cosmetic

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Latisse (Bimatoprost) (CAS 155206-00-1) Market

Overview of the regional outlook of the Latisse (Bimatoprost) (CAS 155206-00-1) Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Latisse (Bimatoprost) (CAS 155206-00-1) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Latisse (Bimatoprost) (CAS 155206-00-1), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents

132 Pages
1 Research Methodology And Statistical Scope
1.1 Market Definition And Statistical Scope Of Latisse (Bimatoprost) (Cas 155206-00-1)
1.2 Key Market Segments
1.2.1 Latisse (Bimatoprost) (Cas 155206-00-1) Segment By Type
1.2.2 Latisse (Bimatoprost) (Cas 155206-00-1) Segment By Application
1.3 Methodology & Sources Of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown And Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Latisse (Bimatoprost) (Cas 155206-00-1) Market Overview
2.1 Global Market Overview
2.1.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size (M Usd) Estimates And Forecasts (2020-2033)
2.1.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales Estimates And Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size By Region
3 Latisse (Bimatoprost) (Cas 155206-00-1) Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Product Life Cycle
3.3 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Manufacturers (2020-2025)
3.4 Global Latisse (Bimatoprost) (Cas 155206-00-1) Revenue Market Share By Manufacturers (2020-2025)
3.5 Latisse (Bimatoprost) (Cas 155206-00-1) Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.6 Global Latisse (Bimatoprost) (Cas 155206-00-1) Average Price By Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
3.8 Latisse (Bimatoprost) (Cas 155206-00-1) Market Competitive Situation And Trends
3.8.1 Latisse (Bimatoprost) (Cas 155206-00-1) Market Concentration Rate
3.8.2 Global 5 And 10 Largest Latisse (Bimatoprost) (Cas 155206-00-1) Players Market Share By Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Latisse (Bimatoprost) (Cas 155206-00-1) Industry Chain Analysis
4.1 Latisse (Bimatoprost) (Cas 155206-00-1) Industry Chain Analysis
4.2 Market Overview Of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development And Dynamics Of Latisse (Bimatoprost) (Cas 155206-00-1) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 Pest Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions And Their Impacts To Latisse (Bimatoprost) (Cas 155206-00-1) Market
5.7 Esg Ratings Of Leading Companies
6 Latisse (Bimatoprost) (Cas 155206-00-1) Market Segmentation By Type
6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
6.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales Market Share By Type (2020-2025)
6.3 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Market Share By Type (2020-2025)
6.4 Global Latisse (Bimatoprost) (Cas 155206-00-1) Price By Type (2020-2025)
7 Latisse (Bimatoprost) (Cas 155206-00-1) Market Segmentation By Application
7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
7.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Sales By Application (2020-2025)
7.3 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size (M Usd) By Application (2020-2025)
7.4 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales Growth Rate By Application (2020-2025)
8 Latisse (Bimatoprost) (Cas 155206-00-1) Market Sales By Region
8.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Region
8.1.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Region
8.1.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales Market Share By Region
8.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Region
8.2.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Region
8.2.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Market Share By Region
8.3 North America
8.3.1 North America Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Country
8.3.2 North America Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Country
8.4.2 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Region
8.5.2 Asia Pacific Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Country
8.6.2 South America Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East And Africa
8.7.1 Middle East And Africa Latisse (Bimatoprost) (Cas 155206-00-1) Sales By Region
8.7.2 Middle East And Africa Latisse (Bimatoprost) (Cas 155206-00-1) Market Size By Region
8.7.3 Saudi Arabia Market Overview
8.7.4 Uae Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Latisse (Bimatoprost) (Cas 155206-00-1) Market Production By Region
9.1 Global Production Of Latisse (Bimatoprost) (Cas 155206-00-1) By Region(2020-2025)
9.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Revenue Market Share By Region (2020-2025)
9.3 Global Latisse (Bimatoprost) (Cas 155206-00-1) Production, Revenue, Price And Gross Margin (2020-2025)
9.4 North America Latisse (Bimatoprost) (Cas 155206-00-1) Production
9.4.1 North America Latisse (Bimatoprost) (Cas 155206-00-1) Production Growth Rate (2020-2025)
9.4.2 North America Latisse (Bimatoprost) (Cas 155206-00-1) Production, Revenue, Price And Gross Margin (2020-2025)
9.5 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Production
9.5.1 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Production Growth Rate (2020-2025)
9.5.2 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Production, Revenue, Price And Gross Margin (2020-2025)
9.6 Japan Latisse (Bimatoprost) (Cas 155206-00-1) Production (2020-2025)
9.6.1 Japan Latisse (Bimatoprost) (Cas 155206-00-1) Production Growth Rate (2020-2025)
9.6.2 Japan Latisse (Bimatoprost) (Cas 155206-00-1) Production, Revenue, Price And Gross Margin (2020-2025)
9.7 China Latisse (Bimatoprost) (Cas 155206-00-1) Production (2020-2025)
9.7.1 China Latisse (Bimatoprost) (Cas 155206-00-1) Production Growth Rate (2020-2025)
9.7.2 China Latisse (Bimatoprost) (Cas 155206-00-1) Production, Revenue, Price And Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Allergan Plc (Abbvie Inc.)
10.1.1 Allergan Plc (Abbvie Inc.) Basic Information
10.1.2 Allergan Plc (Abbvie Inc.) Latisse (Bimatoprost) (Cas 155206-00-1) Product Overview
10.1.3 Allergan Plc (Abbvie Inc.) Latisse (Bimatoprost) (Cas 155206-00-1) Product Market Performance
10.1.4 Allergan Plc (Abbvie Inc.) Business Overview
10.1.5 Allergan Plc (Abbvie Inc.) Swot Analysis
10.1.6 Allergan Plc (Abbvie Inc.) Recent Developments
10.2 Sandoz(Novartis)
10.2.1 Sandoz(Novartis) Basic Information
10.2.2 Sandoz(Novartis) Latisse (Bimatoprost) (Cas 155206-00-1) Product Overview
10.2.3 Sandoz(Novartis) Latisse (Bimatoprost) (Cas 155206-00-1) Product Market Performance
10.2.4 Sandoz(Novartis) Business Overview
10.2.5 Sandoz(Novartis) Swot Analysis
10.2.6 Sandoz(Novartis) Recent Developments
10.3 Hi-tech Pharmacal
10.3.1 Hi-tech Pharmacal Basic Information
10.3.2 Hi-tech Pharmacal Latisse (Bimatoprost) (Cas 155206-00-1) Product Overview
10.3.3 Hi-tech Pharmacal Latisse (Bimatoprost) (Cas 155206-00-1) Product Market Performance
10.3.4 Hi-tech Pharmacal Business Overview
10.3.5 Hi-tech Pharmacal Swot Analysis
10.3.6 Hi-tech Pharmacal Recent Developments
10.4 Apotex Inc.
10.4.1 Apotex Inc. Basic Information
10.4.2 Apotex Inc. Latisse (Bimatoprost) (Cas 155206-00-1) Product Overview
10.4.3 Apotex Inc. Latisse (Bimatoprost) (Cas 155206-00-1) Product Market Performance
10.4.4 Apotex Inc. Business Overview
10.4.5 Apotex Inc. Recent Developments
11 Latisse (Bimatoprost) (Cas 155206-00-1) Market Forecast By Region
11.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Forecast
11.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Forecast By Region
11.2.1 North America Market Size Forecast By Country
11.2.2 Europe Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Forecast By Country
11.2.3 Asia Pacific Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Forecast By Region
11.2.4 South America Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Forecast By Country
11.2.5 Middle East And Africa Forecasted Sales Of Latisse (Bimatoprost) (Cas 155206-00-1) By Country
12 Forecast Market By Type And By Application (2026-2033)
12.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Forecast By Type (2026-2033)
12.1.1 Global Forecasted Sales Of Latisse (Bimatoprost) (Cas 155206-00-1) By Type (2026-2033)
12.1.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size Forecast By Type (2026-2033)
12.1.3 Global Forecasted Price Of Latisse (Bimatoprost) (Cas 155206-00-1) By Type (2026-2033)
12.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Forecast By Application (2026-2033)
12.2.1 Global Latisse (Bimatoprost) (Cas 155206-00-1) Sales (K Mt) Forecast By Application
12.2.2 Global Latisse (Bimatoprost) (Cas 155206-00-1) Market Size (M Usd) Forecast By Application (2026-2033)
13 Conclusion And Key Findings
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.